Effects of TNCB sensitization in DS-Nh mice, serving as a model of atopic dermatitis, in comparison with NC/Nga mice

International Archives of Allergy and Immunology

Volumn 136, Issue 2, 2005, Pages 173-180

  Matsukura, Setsuko ^a   Aihara, Michiko ^a   Hirasawa, Tsutomu ^b   Ikezawa, Zenro ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

Author keywords

2,4,6 trinitrochlorobenzene; Atopic dermatitis; Ds nh mouse; Nc nga mouse; Splenocyte culture

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 13; PICRYL CHLORIDE; STAPHYLOCOCCUS ENTEROTOXIN B; ENTEROTOXIN; ENTEROTOXIN B, STAPHYLOCOCCAL; HAPTEN;

ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; SKIN WATER LOSS; SPLEEN CELL; STAPHYLOCOCCUS AUREUS; TH1 CELL; TH2 CELL; ANIMAL; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; CYTOLOGY; DISEASE MODEL; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOUSE STRAIN; SPLEEN;

ANIMALS; CYTOKINES; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; ENTEROTOXINS; FEMALE; HAPTENS; IMMUNOGLOBULIN E; MICE; MICE, INBRED STRAINS; PICRYL CHLORIDE; SPLEEN; STAPHYLOCOCCUS AUREUS; TH1 CELLS; TH2 CELLS;

EID: 15844431418     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083326     Document Type: Article

References (29)

1. Pastore S, Mascia F, Giustizieri ML, Gianetti A, Girolomoni G: Pathogenic mechanisms of atopic dermatitis. Arch Immunol Ther Exp 2000;48:497-504.
2. Leung DYM: Atopic dermatitis: New insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000;105:860-876.
3. Romamgnani S: The role of lymphocytes in allergic disease. J Allergy Clin Immunol 2000;105:399-408.
4. Akdis CA, Akdis M, Traumann A, Blaser K: Immune regulation in atopic dermatitis. Cur Opin Immunol 2000;12:641-646.
5. Leung DYM: Atopic dermatitis: immunobiology and treatment with immune modulators. Clin Exp Immunol 1997;107:25-30.
6. Jujo K, Renz H, Abe J, Gelfand EW, Leung DYM: Decreased interferon gamma and increased interleukin-4 in atopic dermatitis promotes IgE synthesis. J Allergy Clin Immunol 1992;90:323-331.
7. Poulsen LK, Reimert CM, Bindslev-Jensen C, Hansen MB, Bendzen K: Biomolecular regulation of the IgE immune response. In vitro IgE synthesis and spontaneous production of cytokines. Int Ach Allergy Immunol 1995;106:55-61.
8. Grewe M, Gyufko K, Schopf E, Krutmann J: Lesional expression of interleukin-gamma in atopic eczema. Lancet 1994;343:25-26.
9. Grewe M, Walther S, Gyufko K, Czech W, Schopf E, Krutmann J: Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol 1995;105:407-410.
10. Hoeger PH, Lenz A, Boutnnier A, Fournier JM: Staphylococcal skin colonization in children with atopic dermatitis: Prevalence, persistence, and transmission of toxigenic and nontoxigenic strains. J Infect Dis 1992;165:1064-1068.
11. Leung DYM, Harbeck P, Bina R, Reiser E, Yang DA, Norris JM, Hanifin JM, Sampson HA: Presence of IgE antibodies to staphylococcal enterotoxins on the skin of patients with atopic dermatitis: Evidence for a new group of allergens. J Clin Invest 1993;92:1374-1380.
12. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL: Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151-1160.
13. Haraguchi M, Hino M, Tanaka H, Maru M: Naturally occurring dermatitis associated with Staphylococcus aureus in DS-Nh mice. Exp Anim 1997;46:225-229.
14. Hikita I, Yoshioka T, Mizoguchi T, Tsukahara K, Tsuru K, Nagai H, Hirasawa T, Tsuruta Y, Suzuki R, Ichibashi M, Horikawa T: Characterization of dermatitis arising spontaneously in DS-Nh mice maintained under conventional conditions: Another possible model for atopic dermatitis. J Dermatol Sci 2002;30:142-153.
15. Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J, Matsumoto M, Ushio H, Saito S, Askenase PW, Ra CR: Development of atopic dermatitis-like skin lesion with IgE hyper production in NC/Nga mice. Int Immunol 1996;3:461-466.
16. Habu Y, Seki S, Takayama E, Ohkawa T, Koike Y, Ami K, Majima T, Hiraide H: The mechanism of a defective IFN-γ response to bacterial toxins in an atopic dermatitis model, NC/Nga mice, and the therapeutic effect of IFN-γ, IL-12, or Il-18 on dermatitis. J Immunol 2001;166:5439-5347.
17. Tsudzuki M, Watanabe N, Wada A, Nakane Y, Hiroi J, Matsuda H: Genetic analysis for dermatitis and IgE hyperproduction in the NC/ Nga mice. Immunogenetics 1997;47:88-90.
18. Aioi A, Tonogaito H, Suto H, Hamada K, Ra CR, Ogawa H, Maibach H, Matsuda H: Impairment of skin barrier function in NC/Nga Tnd mice as a possible model for atopic dermatitis. Br J Dermatol 2001;144:12-18.
19. Morita E, Kaneko S, Hiragun T, Shindo H, Tanaka T, Furukawa T, Nobukiyo A, Yamamoto S: Fur mite induce dermatitis associated with IgE hyperproduction in a inbred strain of mice, NC/Kuj. J Dermatol Sci 1999;19:37-43.
20. Matsumoto M, Ra C, Kuwamoto K, Sato H, Itakura A, Sawada J, Ushio H, Suto H, Mitsuishi K, Hikasa Y, Matsuda H: IgE hyperproduction through enhanced tyrosine phosphorylation of Jenus kinase 3 in Nc/Nga mice, a model for human atopic dermatitis. J Immunol 1999;162:1056-1063.
21. Tada J, Akiyama H, Arata J: Bacterial infection and allergic skin disease. Allergology 2000;9:283-288.
22. Akdis M, Simon HU, Weigl L, Kreyden O, Blaser K, Akdis CA: Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis. J Immunol 1999;163:466-475.
23. Akdis CA, Akdis M, Simon D, Dibbert B, Weber M, Gratzl S, Kreyden O, Disch R, Wathrich B, Blaser K, Simon HU: T-cells and T-cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. J Invest Dermatol 1999;113:628-635.
24. Scheerens H, Buckley TL, Muis TL, Garssen J, Dormans J, Nijkamp FP, Van Loveren H: Long-term topical exposure to toluene diisocyanate in mice leads to antibody production and in vivo airway hyperresponsiveness three hours after intranasal challenge. Am J Respir Crit Care Med 1999;159:1074-1080.
25. Fuhlbrigge RC, Kieffer JD, Armerding D, Kupper TS: Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin homing T cells. Nature 1997;389:978-981.
26. Vollenweider S, Saurat JH, Rocken M, Hauser C: Evidence suggesting involvement of Il-4 production in spontaneous in vitro IgE synthesis in patients with atopic dermatitis. J Allergy Clin Immunol 1991;87:1088-1095.
27. de Waal Malefyt R, Abrams JS, Zurawski SM, Lecron JC, Mohan-Peterson S, Sanjanwala B, Bennet B, Silver J, de Vries JE, Yssel H: Differential regulation of IL-13 and Il-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 T cell clones and EBV-transformed B cells. Int Immunol 1995;7:1405-1416.
28. de Vries JE. The role of IL-13 and its receptor in allergy and inflammatory response. J Allergy Clin Immunol 1998;102:165-169.
29. Punnonen J, Aversa G, Cocks BG, Mackenzie AN, Menon S, Zurawski G, de Waal Malefyt R, de Vries JE: Interleukin-13 induces interleukin-4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 1993;90:3730-3734.